SecProbe.io - Filing

CORRESP Filing

Propanc Biopharma, Inc.
Date: July 31, 2025 · CIK: 0001517681 · Accession: 0001641172-25-021649

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-282886

Date

May 30, 2025

Author

Very

Form

CORRESP

Company

Propanc Biopharma, Inc.

Letter

Re: Propanc Biopharma, Inc.

July 30, 2025

United States Securities and Exchange Commission

Division of Corporation Finance

Attn: Tyler Howes

F Street, N.E.

Washington, DC 20549

Amendment No. 6 to Registration Statement on Form S-1

Filed May 30, 2025

File No. 333-282886

Ladies and Gentlemen:

The undersigned registrant (the "Registrant") hereby requests that the Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Amended Registration Statement on Form S-1 to become effective on July 31, 2025 at 4:00 p.m. Eastern Daylight Time, or as soon thereafter as practicable.

The Registrant authorizes Chase Chandler of Brunson Chandler & Jones, PLLC, outside counsel to the Registrant, to verbally alter the requested date and time of effectiveness of the Registration Statement with the Commission. Please call Mr. Chandler at (801) 303-5772 with any questions.

Very
truly yours,
Propanc Biopharma, Inc.

Show Raw Text

CORRESP
 1
 filename1.htm

 July
30, 2025

 United
States Securities and Exchange Commission

 Division
of Corporation Finance

 Attn:
Tyler Howes

 100
F Street, N.E.

 Washington,
DC 20549

 Re:
 Propanc Biopharma, Inc.

 Amendment No. 6 to Registration
 Statement on Form S-1

 Filed May 30, 2025

 File No. 333-282886

 Ladies
and Gentlemen:

 The
undersigned registrant (the "Registrant") hereby requests that the Securities and Exchange Commission (the "Commission")
take appropriate action to cause the above-referenced Amended Registration Statement on Form S-1 to become effective on July 31, 2025
at 4:00 p.m. Eastern Daylight Time, or as soon thereafter as practicable.

 The
Registrant authorizes Chase Chandler of Brunson Chandler & Jones, PLLC, outside counsel to the Registrant, to verbally alter the
requested date and time of effectiveness of the Registration Statement with the Commission. Please call Mr. Chandler at (801) 303-5772
with any questions.

 Very
truly yours,

 Propanc Biopharma, Inc.

 /s/
 James Nathanilesz

 James Nathanilesz

 Chief Executive Officer